Pacira BioSciences, Inc. (PCRX) Profit Margins
Over the twelve months to 2026-06-30, Pacira BioSciences, Inc. (PCRX) had gross margin 79.2%, operating margin 2.7%, net margin 2.0%, free cash flow margin 24.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PCRXPacira BioSciences, Inc.Follow PCRX — free
—
Price chart with a free account
- Market cap
- 1.5B
- P/E TTM
- 104.1
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -6.7% | 17.8% | 36.0% | 60.8% | 71.1% | 60.2% | 69.3% | 73.9% | 74.5% | 72.7% | 74.1% | 70.1% | 72.6% | 75.7% | 79.4% | 79.2% | |
| Operating margin | -249.2% | -126.1% | -62.3% | -2.6% | 3.8% | -11.6% | -8.7% | 4.8% | 2.5% | 10.8% | 16.6% | 9.0% | 13.0% | -10.5% | 2.6% | 2.7% | |
| Net margin | -276.2% | -133.8% | -74.7% | -6.9% | 0.7% | -13.7% | -14.9% | -0.1% | -2.6% | 33.9% | 7.8% | 2.4% | 6.2% | -14.2% | 1.0% | 2.0% | |
| FCF margin | -236.9% | -226.1% | -65.5% | 1.8% | -4.9% | 3.2% | -0.5% | 10.3% | 14.4% | 9.1% | 14.7% | 17.3% | 20.7% | 25.5% | 18.8% | 24.1% |
USD billions · SEC XBRL
Pacira BioSciences, Inc. — questions
- What is Pacira BioSciences, Inc.'s gross margin?
- 79.2% over the twelve months to 2026-06-30.
- What is Pacira BioSciences, Inc.'s operating margin?
- 2.7% over the twelve months to 2026-06-30.
- What is Pacira BioSciences, Inc.'s net profit margin?
- 2.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Pacira BioSciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.